Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Statistics in Biopharmaceutical Research|October 12, 2020
Interim Monitoring for Futility in Clinical Trials with Two Co-primary Endpoints Using PredictionKoko Asakura, Scott R Evans, Toshimitsu HamasakiJournal of Biopharmaceutical Statistics|October 31, 2017
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A reviewToshimitsu Hamasaki, Scott R Evans, Koko AsakuraBiometrical Journal. Biometrische Zeitschrift|October 21, 2016
Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpointsKoko Asakura, Toshimitsu Hamasaki, Scott R EvansJournal of Biopharmaceutical Statistics|February 20, 2016
Group-sequential three-arm noninferiority clinical trial designsToshimitsu Ochiai, Toshimitsu Hamasaki, Scott R Evans, et al.Statistics in Biopharmaceutical Research|April 7, 2015
Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary OutcomesToshimitsu Hamasaki, Koko Asakura, Scott R Evans, et al.Statistics in Medicine|March 29, 2014
Sample size determination in group-sequential clinical trials with two co-primary endpointsKoko Asakura, Toshimitsu Hamasaki, Tomoyuki Sugimoto, et al.The Journal of Thoracic and Cardiovascular Surgery|July 31, 2017
Should annuloplasty prosthesis be selected dependent on the location of prolapse in mitral valve repair for type II dysfunction?Naonori Kawamoto, Tomoyuki Fujita, Satsuki Fukushima, et al.Statistics in Biopharmaceutical Research|July 14, 2015
Sample Size Considerations in Clinical Trials when Comparing Two Interventions using Multiple Co-Primary Binary Relative Risk ContrastsYuki Ando, Toshimitsu Hamasaki, Scott R Evans, et al.Molecular Pharmacology|April 19, 2007
Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytesTakashi Ito, Koko Asakura, Katsuhiko Tougou, et al.Frontiers in Nutrition|October 29, 2025
Taxifolin for prevention of COGnitive impairment (T-COG trial): a study protocol for a randomized, double-blind, placebo-controlled trialTetsuya Chiba, Yorito Hattori, Koko Asakura, et al.Pageof 3